Synopsis

From Central America and the southern U.S. border, Krishna Andavolu chronicles the impact of the Trump administration's policies on the lives of thousands seeking asylum. Meanwhile, Vikram Gandhi investigates a troubling practice: individuals compensated by pharmaceutical companies to test unapproved drugs and document adverse reactions.